Loading...
XTAI3054
Market cap58mUSD
Dec 24, Last price  
24.90TWD
1D
2.51%
1Q
9.60%
Jan 2017
-15.12%
Name

LIWANLI Innovation Co Ltd

Chart & Performance

D1W1MN
XTAI:3054 chart
P/E
380.07
P/S
49.87
EPS
0.07
Div Yield, %
0.00%
Shrs. gr., 5y
-4.19%
Rev. gr., 5y
-26.84%
Revenues
39m
+14.41%
1,243,110,0001,019,155,0002,317,240,0002,736,562,0002,443,691,0002,235,930,000834,909,000323,097,000348,213,000185,512,000129,782,000276,879,00047,813,00033,988,00038,887,000
Net income
5m
P
86,816,000117,287,00035,782,000-58,152,000289,775,00015,304,000-103,453,00062,796,00081,910,000891,0002,782,000-13,613,00045,563,000-120,907,0005,103,000
CFO
-50m
L
89,430,00078,412,000-157,772,000-104,023,000-89,820,000473,038,00034,044,000112,684,00096,034,000-123,090,000-109,160,000-36,627,000-61,133,00078,479,000-50,343,000
Dividend
Jun 28, 20180.4 TWD/sh
Earnings
May 30, 2025

Profile

LIWANLI Innovation Co., Ltd. operates in the biomedical science industry. It provides products in the areas of nutrition and healthcare. The company offers Vigoway and powder collection products for male, female, elderly, and children audience. Its products include probiotic enzymes, pro-active nutrients, resveratrol red grape extract, algae DHA soft gels, shea butter with type II collagen soft gels, algae astaxanthin Q10 soft gels, cordyceps militaries powder, tooth guard tablets, bovine and goat's milk bites, bilberry-tablets, DHA and vitamin D3 drops, and other products. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1980 and is based in New Taipei City, Taiwan.
URL
http://www.carry.com.tw
IPO date
Jul 22, 2002
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
38,887
14.41%
33,988
-28.91%
47,813
-82.73%
Cost of revenue
77,201
74,135
96,450
Unusual Expense (Income)
NOPBT
(38,314)
(40,147)
(48,637)
NOPBT Margin
Operating Taxes
(382)
655
11,677
Tax Rate
NOPAT
(37,932)
(40,802)
(60,314)
Net income
5,103
-104.22%
(120,907)
-365.36%
45,563
-434.70%
Dividends
Dividend yield
Proceeds from repurchase of equity
(81,437)
BB yield
3.82%
Debt
Debt current
2,275
2,288
3,109
Long-term debt
1,197
2,141
1,282
Deferred revenue
Other long-term liabilities
1,172
2,014
2,014
Net debt
(327,833)
(364,635)
(299,879)
Cash flow
Cash from operating activities
(50,343)
78,479
(61,133)
CAPEX
(112)
(387)
(2,175)
Cash from investing activities
(24)
3,394
45,959
Cash from financing activities
(469)
(1,398)
(107,531)
FCF
(69,877)
(39,489)
33,310
Balance
Cash
356,411
386,295
511,547
Long term investments
(25,106)
(17,231)
(207,277)
Excess cash
329,361
367,365
301,879
Stockholders' equity
835,403
713,203
810,162
Invested Capital
457,960
403,134
589,855
ROIC
ROCE
EV
Common stock shares outstanding
80,653
80,651
82,634
Price
21.00
5.26%
19.95
-22.67%
25.80
7.50%
Market cap
1,693,713
5.27%
1,608,988
-24.53%
2,131,957
6.50%
EV
1,395,492
1,279,557
1,832,078
EBITDA
(34,058)
(34,316)
(41,130)
EV/EBITDA
Interest
582
313
512
Interest/NOPBT